PharmiWeb Recruiter Blog

Moderna

CEPI and Moderna Harness mRNA Technology to Advance 100 Days Mission

  • New partnership will harness Moderna's mRNA rapid-response platform, clinically validated during the COVID-19 pandemic, to accelerate epidemic and pandemic vaccine development
  • First project will enable rapid pre-clinical testing of antigen designs for high-risk viral families, to advance global outbreak readiness

CAMBRIDGE, MA / ACCESSWIRE / October 30, 2023 / The Coalition for Epidemic Preparedness Innovations (CEPI) and Moderna, Inc. (NASDAQ:MRNA) have entered into a strategic partnership that will harness Moderna's mRNA platform to accelerate the development of vaccines against viral disease outbreaks that threaten global health. The work undertaken as part of this partnership could expand the infectious disease targets for mRNA vaccine technology and strengthen pandemic preparedness and public health efforts in alignment with the 100 Days Mission, a global goal to compress vaccine development timelines to 100 days.

Read more
Moderna

Moderna Named a Top Employer by Science for Ninth Consecutive Year

CAMBRIDGE, MA / ACCESSWIRE / October 26, 2023 / Moderna, Inc. (NASDAQ:MRNA) today announced it was ranked as one of the top employers in the global biopharmaceutical industry in Science and Science Careers' 2023 Top Employers Survey for the ninth consecutive year. Moderna was recognized for its commitment to continuous innovation, treating employees with respect, and social responsibility.

Read more
Improve the Visibility of your Life Science Job Adverts

When is the Best Time to Post Your Jobs?

As a life science recruiter or hiring manager, posting your jobs at the right time is crucial for several reasons. First and foremost, it increases the visibility of your job postings. By strategically timing your posts, you can ensure that they appear at the top of search results when candidates are actively searching for new opportunities.

Read more
Regeneron

Regeneron Builds on Together for Change™ Initiative with Five-Year, $5 Million Commitment to Fuel the STEM Talent Pipeline in Nashville, TN

  • Commitment builds on Regeneron’s longstanding efforts to develop the STEM talent pipeline as lead sponsor of the premier high school competitions, the Regeneron Science Talent Search (STS) and Regeneron International Science and Engineering Fair (ISEF)
  • Regeneron will adapt successful initiatives it co-created in its local New York-based community to Nashville’s unique STEM ecosystem, helping to advance students to these premier competitions and inspire STEM careers
  • Alongside this commitment, Regeneron is participating in Together for CHANGE, a national health and education equity initiative established by Nashville-based Meharry Medical College, further fueling the STEM talent pipeline

TARRYTOWN, N.Y., Oct. 18, 2023 (GLOBE NEWSWIRE) -- Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced a five-year, $5 million strategic investment to bolster Nashville, Tennessee’s science, technology, engineering and mathematics (STEM) ecosystem through high-quality, equitable engagement programs for students and science teachers. Regeneron’s goal is to engage and inspire the next generation of scientific leaders and innovators to help address some of humanity’s most challenging existential threats.

Read more
James Lind and the Birth of Clinical Trials

James Lind and the Birth of Clinical Trials

The realm of modern medicine stands on the shoulders of groundbreaking scientific discoveries and milestones that have shaped our understanding of diseases, treatments, and patient care. Amongst these milestones, one particular event emerged as a turning point in the history of medical research – the first recorded clinical trial.

Read more
Parexel

Global Investigative Sites Recognize Parexel with the 2023 Society for Clinical Research Sites Eagle Award

DURHAM, N.C., Oct. 12, 2023 (GLOBE NEWSWIRE) -- Parexel, one of the world’s largest clinical research organizations (CROs) providing the full range of Phase I to IV clinical development services, today announced it has been awarded the 2023 Society for Clinical Research Sites (SCRS) Eagle Award (CRO category). Parexel received the award at the annual Global Site Solutions Summit held Oct. 6-8 in Hollywood, Fla. The SCRS Eagle Award recognizes the sponsor and CRO committed to outstanding leadership, professionalism, integrity, passion and dedication to advancing the clinical research profession through strong site partnerships.

Read more